News

VIDEO: Longer period of postpartum thromboembolic risk raises therapeutic questions


 

Findings from a large study of women following their first pregnancy extend the postpartum period of heightened risk for thromboembolic events from the previously known 6 weeks to 12 weeks, leaving physicians with new questions that need to be answered in further studies about the need for longer periods of anticoagulation therapy in some women. In a video interview, Dr. Bruce Ovbiagele of the Medical University of South Carolina, Charleston, comments on the findings at the International Stroke Conference. The study also was published Feb. 13 in the New England Journal of Medicine in conjunction with the report at the conference (2014 Feb. 13 [doi:10.1056/NEJMoa1311485).

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Chest pain traits didn’t identify MI in women
MDedge ObGyn
No link between herpes zoster in elderly and varicella vaccination
MDedge ObGyn
Folic acid supplementation low among women with epilepsy
MDedge ObGyn
Earlier epilepsy surgery may have reproductive benefits for women
MDedge ObGyn
Drug or sham? Migraineurs responded to placebo 40% of the time
MDedge ObGyn
New stroke guidelines focus on women’s risks
MDedge ObGyn
NSAID makers argue against new warnings on CV risks
MDedge ObGyn
No new cardiovascular warnings needed for NSAIDs say FDA advisers
MDedge ObGyn
VIDEO: Postpartum elevated thrombosis risk lasts 12 weeks
MDedge ObGyn
Postpartum thrombosis risk high for 12 weeks
MDedge ObGyn

Related Articles